Mulpleta (lusutrombopag)

Manufacturer:
Shionogi
Route of Administration: 
Oral
Site of Care:
Outpatient
Website: 
  • Manufacturer Website
Enrollment Forms:
Synergen Prescription Form

Approved Indication:

treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure

Conditions:

  • Thrombocytopenia
  • Chronic Liver Disease

Therapeutic Area:

  • Hepatology